# Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

> **NCT06272214** · PHASE2 · RECRUITING · sponsor: **Zhejiang Cancer Hospital** · enrollment: 146 (estimated)

## Conditions studied

- Adjuvant Radiotherapy

## Interventions

- **RADIATION:** Adjuvant radiotherapy
- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT06272214
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2027-03-01
- **Final completion:** 2029-03-01
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2024-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06272214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06272214, "Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06272214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*